Delivery Order SPE2DB20D3101-SPE2DB25FREX9

Award Date 3/19/25
Potential Completion Date 3/20/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,182.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it has an ultimate completion date of January 29, 2025. The contract covers the delivery of "TESTOSTERONE CYP 200 MG/MLML", a pharmaceutical product, to support federal healthcare programs. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,970.00 firm fixed-price Delivery Order contract is for the supply of "TESTOSTERONE CYP 200 MG/MLML" and has an ultimate completion date of June 3, 2024. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award is for a delivery order with a ceiling value of $1,027.84, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price arrangement for the supply of "TESTOSTERONE CYP 200 MG/MLML", with a period of performance through January 6, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical...
This federal contract award, valued at $2,897.71, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of Testosterone Cypionate 200 mg/mL, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and a completion date of November 15, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, with a significant Indefinite Delivery...
This federal contract award is for the delivery of TESTOSTERONE CYP 200 MG/MLML pharmaceuticals, with a ceiling value of $1,487.70. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,117.37, is for the delivery of 4563347537 ! TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM. The contract has a completion date of January 18, 2024 and is a Firm Fixed Price Delivery Order. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999...
This federal contract award, valued at $2,172.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Testosterone Cypionate 200 mg/mL, a testosterone replacement therapy medication. The contract has an ultimate completion date of March 24, 2025 and uses a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,416.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Testosterone Cypionate 200 mg/mL, a testosterone replacement therapy medication. The contract has an ultimate completion date of March 7, 2025 and uses a Firm Fixed Price pricing type. It is not designated with a set-aside requirement, indicating...
This federal contract award, valued at $2,228.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4554441054 - Testosterone Cyp 200 mg/mL medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,599.84 firm fixed-price contract is for the delivery of testosterone cypionate 200 mg/mL medication, with a completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FREX9
    Delivery Order

This federal contract award, valued at $2,905.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567632676 ! TESTOSTERONE CYP 200 MG/MLML and has an ultimate completion date of March 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 6/18/25, 11:37 AM